Machine Learning in Pharmaceutical Market Trends

Request Free Sample Copy

Report ID: 3449
Published Date: Dec 24, 2024
Report Format: PDF, PPT

Buy Now

Machine Learning in Pharmaceutical Sector: Growth Drivers and Challenges

Growth Drivers

Increasing Adoption of Artificial Intelligence
Growing Need for Advanced Technology in Medical Sector

Challenges

Lack of Resources in the Developing and Under Developed Countries

Base Year	2023
Forecast Year	2024–2036
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Machine Learning in Pharmaceutical Market Size, Growth Report 2037

Frequently Asked Questions (FAQ)

Machine Learning in Pharmaceutical Market size is set to register remarkable growth rate during the forecast period i.e., between 2025-2037.

Increasing adoption of artificial intelligence, and growing need for advanced technology in medical sector to boost the market growth.

North America industry is estimated to dominate majority revenue share by 2037, owing to the presence of major pharmaceutical companies in the region, along with constant advancements in the medical sector.

The major players in the market are Cyclica Inc., BioSymetrics Inc., Cloud Pharmaceuticals, Inc., Deep Genomics, Atomwise Inc., Alphabet Inc., and others.